Get Our Top Trade Ideas Delivered Daily - 65% Off Now

+ New Watchlist

Benzinga Research

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

BioNTech

BNTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$113.59

1.311.17%

Last update: 9:46 AM

15 minutes delayed

BioNTech (BNTX) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for BioNTech (NASDAQ:BNTX) Stock

BioNTech Stock (NASDAQ: BNTX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Sunday, September 22, 2024

Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Lekha Gupta

Friday, September 20, 2024

Pfizer And BioNTech Receive Positive CHMP Opi...
Benzinga Newsdesk

Thursday, September 19, 2024

Deutsche Bank Maintains Buy on BioNTech, Rais...
Benzinga Newsdesk
Watching BioNTech; Traders Circulating Stock ...
Benzinga Newsdesk

Wednesday, September 18, 2024

UBS Maintains Neutral on BioNTech, Raises Pri...
Benzinga Newsdesk

Tuesday, September 17, 2024

Decoding BioNTech's Options Activity: What's the Big Picture?
Benzinga Insights
Jefferies Upgrades BioNTech to Buy, Raises Pr...
Benzinga Newsdesk

Monday, September 16, 2024

DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
Vandana Singh
BioNTech shares are trading higher B of A Sec...
Benzinga Newsdesk
JP Morgan Upgrades BioNTech to Neutral, Raise...
Benzinga Newsdesk
B of A Securities Maintains Buy on BioNTech, ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BioNTec...
Benzinga Newsdesk

Sunday, September 15, 2024

Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
Lekha Gupta

Friday, September 13, 2024

Forecasting The Future: 8 Analyst Projections For BioNTech
Benzinga Insights
Jefferies Maintains Hold on BioNTech, Raises ...
Benzinga Newsdesk
"Florida Discourages Use Of mRNA Covid Vaccin...
Benzinga Newsdesk
Market Whales and Their Recent Bets on BNTX Options
Benzinga Insights

Wednesday, September 11, 2024

GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech
Vandana Singh

Monday, September 09, 2024

Why Is Moderna Stock Trading Higher On Monday?
Vandana Singh

Friday, September 06, 2024

Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
Vandana Singh

Thursday, September 05, 2024

BioNTech To Present Clinical Trial Data For S...
Benzinga Newsdesk

Wednesday, September 04, 2024

Tempus Announces Real World Data Collaboratio...
Benzinga Newsdesk

Tuesday, September 03, 2024

UK, Taiwan Approve Moderna's Updated COVID-19 Shot
Vandana Singh

Thursday, August 29, 2024

Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
Vandana Singh

Tuesday, August 27, 2024

HC Wainwright & Co. Reiterates Buy on BioNTec...
Benzinga Newsdesk

Monday, August 26, 2024

Americans To Access COVID-19 Test Kits For Free As US Government Restarts Free At-Home Program
Vandana Singh

Friday, August 23, 2024

U.S. CDC Says For This Season Peak Hospitaliz...
Benzinga Newsdesk

Thursday, August 22, 2024

FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot
Vandana Singh
FDA Authorizes Updated Covid-19 Vaccines By M...
Benzinga Newsdesk

Tuesday, August 20, 2024

WHO Official Hans Kluge Asserts Mpox Is Not T...
Benzinga Newsdesk

Monday, August 19, 2024

FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Michael Juliano
BioNTech shares are trading higher after the ...
Benzinga Newsdesk
FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose
Vandana Singh
Unveiling 12 Analyst Insights On BioNTech
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on BioNTec...
Benzinga Newsdesk

Friday, August 16, 2024

Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
Vandana Singh
BioNTech shares are trading lower after the c...
Benzinga Newsdesk
Pfizer And BioNTech Provide Update On mRNA-ba...
Benzinga Newsdesk

Thursday, August 15, 2024

JP Morgan Maintains Underweight on BioNTech, ...
Benzinga Newsdesk

Tuesday, August 13, 2024

Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
Vandana Singh
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
Vandana Singh

Wednesday, August 07, 2024

This Cognizant Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
Avi Kapoor
Deutsche Bank Upgrades BioNTech to Buy, Maint...
Benzinga Newsdesk

Tuesday, August 06, 2024

University Of Pennsylvania Sues BioNTech For ...
Benzinga Newsdesk
TD Cowen Maintains Hold on BioNTech, Lowers P...
Benzinga Newsdesk

Monday, August 05, 2024

US Stocks Trim Black Monday's Drops As Services Gauge Expands, Bond Gains Stall As Traders Reassess Fed Cuts: What's Driving Markets?
Piero Cingari
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
Vandana Singh
Nasdaq, R2K Futures Tumble Over 4%, VIX Spikes Over 100%, Bitcoin Plunges Hard As Global Sell-Off Deepens Amid Recession Fears
Shanthi Rexaline
BioNTech Reiterates 2024 Revenues Guidance Of...
Benzinga Newsdesk
BioNTech Q2 2024 GAAP EPS EUR(3.36) Misses EU...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved